Lines of Research
Clinical
Cannabidiol in the treatment of schizophrenia
COVID and mental illness
Efficacy of Clozapine in psychosis and intellectual disability
Family metacognitive training in mothers with psychosis and their adolescent children
Suicide prevention and intervention
Resistance to conventional treatments: clinical and biomarker study
Metabolic syndrome and psychosis
Experimental
Activation of maternal immunity and neurodevelopmental alterations
MIA preclinical murine model of neurodevelopmental disorders and mental illness
Preclinical murine models and psychosis based on double hit hypothesis: MIA and Cannabis (THC)
Characterization of psychotropic drugs and their mechanisms of action: Clozapine
Inflammation and alterations in postnatal neurogenesis
Role of ADAMTS2 metalloprotease in schizophrenia
Clinical
Cannabidiol in the treatment of schizophrenia
COVID y enfermedad mental
Efficacy of Clozapine in psychosis and intellectual disability
Family metacognitive training for mothers with psychosis and their adolescent children
Suicide prevention and intervention
Resistance to conventional treatments: clinical and biomarker studies
Metabolic syndrome and psychosis
Early detection and intervention clinical cohorts
